MarketInOut Stock Screener Log In | Sign Up

Solasia Pharma KK

TSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Solasia Pharma KK stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSE
Market Capitalization7,371.14 mln
Float245 mln
Earnings Date08/18/2025

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.65
Highly suspicious

Relative Strength

75 / 100
Strongly outperforming

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

-232%
Severely loss-making

ROE

-56.43
Deeply negative

Business Description

Solasia Pharma K.K. is a pharmaceutical company founded in 2006 and based in Minato, Japan, that sells and distributes medicines and medical devices across Japan, China, South Korea, and other markets. Its current lineup includes treatments for mouth sores caused by cancer therapy, a drug for a rare type of blood cancer, and a patch that helps patients manage nausea during chemotherapy. The company is also working on two early-stage treatments aimed at nerve damage and colorectal cancer caused by chemotherapy.

Key Fundamentals

EPS-3.29
ROE-56.43
RPS1.47
ROIC-240
ROA-44.00
Interest Cover-81.09
EBITDA, mln-856
EV / EBITDA-8.47
EV / EBIT-8.15
Revenue, mln388
EV / Revenue18.69

Quote Details

Last 27.00
Change -1 (-3.57%)
Open 28.00
Volume 99,113,800
Turnover 2,676,072,704
Average Volume 84,032,872

Financial Ratios

Pre-Tax Profit Margin-232
Leverage Ratio1.31
Current Ratio4.28
Price / Book5.83
Price / Tangible Book5.83
Debt / Equity0.05
Price / Sales21.02

Financial Strength

Altman Z-Score10.04
Piotroski F-Score 5 / 9
Beneish M-Score-0.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 62 / 100   
1 Month -12.9% 14 / 100   
2 Months 0% 53 / 100   
6 Months -25% 9 / 100   
1 Year -22.86% 13 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog